⏳ Fetching live dividend data...
Home › Calculator › NXLIW Dividend Calculator 2026
Nexalin Technology, Inc. · NASDAQ
Price: $0.01 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in NXLIW → $1.8337939798146806e+31M in 10 years · $1,528,134,452,492,043,800,000,000,000,000,000,000.00/month
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. It also engages in the development of Generation 2, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiates, chronic pain, Alzheimer's disease, and dementia. The company was incorporated in 2021 and is headquartered in Houston, Texas.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime.
Ready to invest? Open NXLIW position with:
Real after-tax yield depends on where you live and how you hold NXLIW.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 14492.75% | 14489.95% | $1,449,275 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 12318.84% | 12316.04% | $1,231,884 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 11594.20% | 11591.40% | $1,159,420 / yr |
| 🇬🇧 UK ISA | 0% | 14492.75% | 14489.95% | $1,449,275 / yr |
| 🇬🇧 UK Taxable | 8.75% | 13224.63% | 13221.83% | $1,322,463 / yr |
| 🇨🇦 TFSA | 0% | 14492.75% | 14489.95% | $1,449,275 / yr |
| 🇨🇦 CA Taxable | 25% | 10869.56% | 10866.76% | $1,086,956 / yr |
| 🇦🇺 Super (pension) | 15% | 12318.84% | 12316.04% | $1,231,884 / yr |
| 🇦🇺 AU Taxable | 30% | 10144.92% | 10142.13% | $1,014,492 / yr |
| 🇩🇪 DE Taxable | 26.375% | 10670.29% | 10667.49% | $1,067,029 / yr |
| 🇫🇷 FR Taxable | 30% | 10144.92% | 10142.13% | $1,014,492 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
NXLIW pays quarterly — 4 times per year. Next ex-div: TBD.
How NXLIW compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for NXLIW sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2025-12-19 | 1,000,000 | $0.83 | $830.0K | ||
| A-Award | 2025-12-19 | 100,000 | $0.83 | $83.0K | ||
| A-Award | 2025-12-19 | 1,000,000 | $0.83 | $830.0K | ||
| A-Award | 2025-12-19 | 100,000 | $0.83 | $83.0K | ||
| A-Award | 2025-12-19 | 100,000 | $0.83 | $83.0K | ||
| A-Award | 2025-12-19 | 100,000 | $0.83 | $83.0K | ||
| A-Award | 2025-09-29 | 83,333 | — | — | ||
| A-Award | 2025-09-29 | 36,459 | — | — | ||
| A-Award | 2025-09-29 | 36,459 | — | — | ||
| A-Award | 2025-09-29 | 36,459 | — | — |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the NXLIW dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →